|97.65||-1.28 / -1.29%|
As of 3:59pm ET
|97.65||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 105.00, with a high estimate of 135.00 and a low estimate of 93.00. The median estimate represents a +7.53% increase from the last price of 97.65.
The current consensus among 5 polled investment analysts is to Hold stock in Ligand Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.